Microstent favoured in France
This article was originally published in Clinica
The AVE Microstent has captured around 26% of the UK market and a significant share of the European market. Dr Bernard Vales' group, from the UCV in Marseille and ICV Paris Sud, France, now use the AVE stent in 90% of stenting procedures. He explained that the multi-length family of stents is much more adaptable to different lesions than other designs. In fact his praise was so glowing that one American member of the audience was led to ask why the Europeans used any other stent. The Palmaz-Schatz stent is used by Dr Vales' group in 5.6%.